Erin McEvoy

Willow Industries recently partnered with the Cannabis Research Coalition to advance cannabis research.

For the third time in recent years, the option to legalize recreational cannabis will be placed before voters in the Mount Rushmore State.

The Cannabis for Private Purposes Act legalizes cannabis for adults while prohibiting public consumption, sales, and detailing measures for protecting children.

A recently added amendment to the 2024 Farm Bill would significantly impact intoxicating hemp-derived products.

This webinar from MM411 explored the far-ranging studies of Dr. Raphael Mechoulam and Dr. Ethan Russo on the science and medicine of cannabis and other plants.

The latest webinar from the GMP Collective discussed the practice of lab shopping and the various causes, effects, and potential solutions.

The nonprofit, which is focused on advancing the cannabis industry, joins a network of industry experts from over a hundred different organizations.

The final installment of this webinar series discussed recommendations for new policies integrating cannabis into harm reduction efforts.

At the Cannabis Science Conference Spring 2024, toxicologist Cristelle Santos provided a deep dive into the need for better cannabis product safety standards.

This hour-long webinar covered consumer safety, interstate commerce, and the need for global standards, highlighting collaboration and evidence-based approaches for future regulatory frameworks.

Here we present a roundup of the interviews, insights, and presentation coverage from both before and during this year’s conference in Kansas City, Missouri from May 7-9, 2024.

In this interview at the Cannabis Science Conference, James Wylde, President and CEO of Greenlight Analytical, discusses new cannabis cultivation tools.

Focusing on the potential effects for medical cannabis patients, Americans for Safe Access held a high-level presentation and discussion on the rescheduling of cannabis.

Live from the Cannabis Science Conference, Julie Kowalski shares her perspective on the conference.

The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.

In this quick, onsite interview, Susan Audino shares the biggest development she saw from the Cannabis Science Conference Spring 2024.

In this quick, onsite interview, Program Chair of the Compliance Track, Kim Stuck, shares the biggest buzz from the Cannabis Science Conference Spring 2024.

At the Cannabis Science Conference, Antonio Timoteo Jr., PhD, presented research on cannabis cultivation practices and optimizing terpene content.

In the Cultivation Track at Cannabis Science Conference, Bernie Lorenz, Chief Science Officer of ProKure Solutions, discussed the intriguing topic of the effects of COVID on cannabis testing methods.

In the General Session of the Cannabis Science Conference, Scheril Murray Powell, Esq. and John Calloway Jr. discussed the many ways equity ties into science in the cannabis industry.

Patrick Bird, Senior Manager of Scientific Affairs at bioMérieux, presented “Innovative Method Development to Meet the Needs for the Cannabis Industry" on the first day of Cannabis Science Conference in the Analytical Track.

As the keynote speaker for Cannabis Science Conference Spring 2024, Jamila Owens-Todd discussed the various ways to approach plant medicine and manufacturing.

Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.

Here, Darwin Millard, Technical Director of CSQ, discusses the present and potential future of cannabis standards and regulations.

In this interview, Darwin Millard shares what attendees will experience in the two ASTM Subcommittee meetings he will be guiding.

In this interview, Jimmy Farrell, Standards Development Manager at ASTM International, explains the important role ASTM plays in safety and quality of the global cannabis industry.

In this interview, Jimmy Farrell explains more on this opportunity to shape standards and methods in the global cannabis industry.

In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.

Kentucky Governor signs HB 829, and introduces lottery for dispensary applications.

In recognizing the 4/20 holiday, here is a selection of regulatory updates and commentary in the cannabis industry this year so far.